Ablation of lncRNA MIAT confers cardioprotection against angiotensin II-induced cardiac hypertrophy and transverse aortic constriction-induced heart failure through augmenting calcium handling and contractility in cardiomyocytes (Yang et al., 2021). Here, AGT is linked to cardiac hypertrophy.